Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
American Journal of Surgery|February 2, 1999
Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancerH M Kuerer, L A Newman, A U Buzdar, et al.Annals of Surgical Oncology|June 28, 2018
Multidisciplinary Intraoperative Assessment of Breast Specimens Reduces Number of Positive MarginsS E Tevis, H B Neuman, E A Mittendorf, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2013
Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancerM M Kim, P Allen, A M Gonzalez-Angulo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2014
Which threshold for ER positivity? a retrospective study based on 9639 patientsM Yi, L Huo, K B Koenig, et al.The Cancer Journal From Scientific American|August 5, 1998
Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node statusH M Kuerer, L A Newman, A U Buzdar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancerT M Breslin, L Cohen, A Sahin, et al.Annals of Surgical Oncology|December 18, 2018
OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer PatientsS E Tevis, R Bassett, I Bedrosian, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapyH M Kuerer, L A Newman, T L Smith, et al.Annals of Surgical Oncology|October 18, 2000
Ductal carcinoma-in-situ: long-term results of breast-conserving therapyN Q Mirza, G Vlastos, F Meric, et al.Journal of the National Cancer Institute|November 8, 2001
Ductal lavage for detection of cellular atypia in women at high risk for breast cancerW C Dooley, B M Ljung, U Veronesi, et al.Pageof 5